Stockholders' Equity (Tables)

12 Months Ended

Jul. 01, 2012

Stockholders' Equity [Abstract]

Stock-based compensation expense included in the consolidated statements of operations

	Year ended
	July 1, 2012		July 3, 2011		June 27, 2010
	(In thousands)
Cost of sales	$	867	$	802	$	802
Research and development		1,183		870		758
Selling, general and administrative		4,092		3,126		2,154
Pre-tax stock-based compensation expense		6,142		4,798		3,714
Less: Income Tax effect		2,273		1,775		1,374
Net Stock-based compensation expense	$	3,869	$	3,023	$	2,340

Stock option and award activity

				Non Performance- based Options Outstanding					Performance-based Options Outstanding					Restricted Stock Outstanding
	Shares Available For Grant			Number of Shares			Weighted Average Exercise Price		Number of Shares			Weighted Average Exercise Price		Number of Shares			Weighted Average Grant-Date Fair Value
	(In thousands, except per share amounts)
Balances at June 28, 2009		7,151			5,290		$	6.53		125		$	8.53		540		$	6.22
Granted—options		(2,683	)		2,683			4.98
Granted—restricted shares		(254	)		—			—		—			—		127			5.25
Exercised		—			(439	)		4.48
Vested		—			—			—		—			—		(373	)		6.69
Canceled		1,655			(1,491	)		7.12		(125	)		8.53		(75	)		5.24
Expired		(172	)		—										—			—
Balances at June 27, 2010		5,697			6,043		$	5.84		—		$	—		219		$	5.20
Granted—options		(2,193	)		2,193			6.20
Granted—restricted shares		(422	)		—			—		—			—		211			6.55
Exercised		—			(462	)		4.69
Vested		—			—			—		—			—		(175	)		5.19
Canceled & Expired		1,457			(1,240	)		7.22		—			—		(27	)		5.78
Expired from plans prior to 1999		(76	)		—										—			—
Balances at July 3, 2011		4,463			6,534		$	5.78		—		$	—		228		$	6.39
Granted—options		(2,109	)		2,109			5.16
Granted—restricted shares		(312	)		—			—		—			—		156			5.32
Exercised		—			(475	)		4.53
Vested		—			—			—		—			—		(123	)		6.53
Cancelled and Expired		852			(852	)		7.07		—			—		—
Shares Expired from plans prior to 1999		(5	)		—			—							—			—
Balances at July 1, 2012		2,889			7,316		$	5.54		—		$	—		261		$	5.68

Options outstanding vested and expected to vest, and exercisable

Option	Number of Shares		Average Remaining Contractual Life		Weighted Average Exercise Price		Aggregate Intrinsic Value
	(In thousands)		(In years)				(In thousands)
Outstanding		7,316		4.60	$	5.54	$	5,152
Vested and expected to vest		7,012		4.54	$	5.54	$	4,956
Exercisable		3,592		3.48	$	5.68	$	2,715

Fair value of stock-based awards to employees

	Year ended
	July 1, 2012			July 3, 2011			June 27, 2010
Expected life (in years)		4.9			5.1			4.9
Risk-free interest rate		0.6	%		1.2	%		1.9	%
Volatility		56.6	%		56.6	%		56.6	%